The aim of this study was to comprehensively examine expression of Caveolin-1 in different benign and malignant breast tissues, including DCIS and invasive breast cancer using tissue microarray (TMA) technology. The gene discussed is CAV1; the disease is ductal breast carcinoma in situ.